H-TYR-GLY-PHE-GLY-GLY-OH
H-TYR-GLY-PHE-GLY-GLY-OH Basic information
- Product Name:
- H-TYR-GLY-PHE-GLY-GLY-OH
- Synonyms:
-
- OSTEOGENIC GROWTH PEPTIDE (10-14)
- OGP (10-14)
- H-TYR-GLY-PHE-GLY-GLY-OH
- historphin
- Glycine, N-(N-(N-(N-L-tyrosylglycyl)-L-phenylalanyl)glycyl)-
- Tyr-Gly-Phe-Gly-gly
- Tyrosyl-glycyl-phenylalanyl-glycyl-glycine
- Glycine, L-tyrosylglycyl-L-phenylalanylglycyl-
- CAS:
- 105250-85-9
- MF:
- C24H29N5O7
- MW:
- 499.52
- Mol File:
- 105250-85-9.mol
H-TYR-GLY-PHE-GLY-GLY-OH Chemical Properties
- Boiling point:
- 1028.0±65.0 °C(Predicted)
- Density
- 1.352±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- pka
- 3.32±0.10(Predicted)
- form
- Solid
- color
- White to off-white
H-TYR-GLY-PHE-GLY-GLY-OH Usage And Synthesis
Uses
Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity. Osteogenic Growth Peptide (10-14) is responsible for the binding to the OGP receptor and activates an intracellular Gi-protein-MAP kinase signaling pathway. Osteogenic Growth Peptide (10-14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10-14) acts as a Src inhibitor[1][2][3][4].
in vivo
Osteogenic Growth Peptide (10-14) (OGP(10-14)) increases bone formation and trabecular bone density and stimulates fracture healing when administered to mice and rats[1].
References
[1] Chen YC, et al. Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10-14). J Med Chem. 2002;45(8):1624-1632. DOI:10.1021/jm010479l
[2] Chen Z, et al. Regulation of endochondral ossification by osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)]. Protein Pept Lett. 2009;16(9):1074-1080. DOI:10.2174/092986609789055395
[3] Fazzi R, et al. Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice. Leuk Res. 2002;26(1) DOI:10.1016/s0145-2126(01)00091-1
[4] Battolla B, et al. The small peptide OGP(10-14) reduces proliferation and induces differentiation of TPO-primed M07-e cells through RhoA/TGFbeta1/SFK pathway. Med Sci Monit. 2011;17(1):SC1-SC5. DOI:10.12659/msm.881309
H-TYR-GLY-PHE-GLY-GLY-OHSupplier
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 010-50973130 18101056239
- 3193328036@qq.com
H-TYR-GLY-PHE-GLY-GLY-OH(105250-85-9)Related Product Information
- PHE-GLY-GLY
- X-GAL
- GP120 (168-182)
- CEF27
- LEU-ALA-TRP-LYS-PHE-ASP-PRO-THR-LEU-ALA-TYR-THR-TYR-GLU-ALA
- H-SER-ALA-GLU-GLU-TYR-GLU-TYR-PRO-SER-OH
- (D-ALA2,MET5)-BETA-CASOMORPHIN (1-5) (BOVINE)
- (D-ALA2)-BETA-CASOMORPHIN (1-5) (BOVINE)
- AC-PTYR-PTYR-PTYR-ILE-GLU-OH
- (P-AMINO-PHE6)-ANGIOTENSIN II
- ALLATOSTATIN I
- (D-PRO2)-BETA-CASOMORPHIN (1-5) (BOVINE)
- H-TYR-GLY-PHE-GLY-GLY-OH
- ATGPLSPGPFGRR
- HEXA-L-TYROSINE
- PHYTOSULFOKINE-ALPHA
- H-ARG-PRO-GLY-GLY-GLY-ASP-MET-ARG-ASP-ASN-TRP-ARG-SER-GLU-LEU-TYR-LYS-TYR-LYS-VAL-OH
- CDR-H3/C2